Eurosets
A Holistic Solution for ECMO and ECLS

With the expansion of clinical indications and increasing evidence on the benefits of extracorporeal oxygenation therapy, compared to conventional therapies, providers are more inclined to adopt devices that are safe, proven, and easy to use. Eurosets, with its long-standing expertise in component innovation for sustainable value creation in the competitive market, is wellpositioned to leverage the growth opportunity arising from recent trends, such as the increasing prevalence of ARDS cases and the COVID-19-induced accelerated demand for extracorporeal membrane oxygenation (ECMO) products. With its commitment to address the market’s ever-evolving needs, Eurosets has partnered with leading companies to develop a specialized device for extracorporeal carbon dioxide removal (ECCO2R) that brings new advancements in the market, a testament to the company’s sustainability.

Eurosets constantly develops new products in the extracorporeal life support (ECLS) segment and is emerging as a solid challenger to established competitors. Recently, the company launched its ECMOLife device—a compact integrated system for ECMO/ECLS therapy—and equipped with non-invasive sensors, ensuring the continuous monitoring of 10 parameters. In addition, the company is launching new devices in the ECMO space and ECCO2R space. Through these new launches, Eurosets is expanding its product line, despite its already strong presence in the European oxygenators market for several years. The company’s CO2 reset device treats chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS) patients who are hypercapnic.

The device is more sophisticated and advanced than competing solutions in terms of integrating into the ICU workflow. Also, Eurosets has the in-house capability to manufacture the ECMO system and related disposables.

Moreover, the ECMOLife is a versatile platform for ECMO and ECLS therapy applications and enables mobility or interfacility transfer through its compact design and proprietary Leonardo trolley. The device is a multi-functional, integrated system that decreases the total cost of ownership and is easy to operate by clinical professionals with less training. Eurosets’s console provides professionals with versatility in therapy administration by combining a full range of functionalities in a single platform, with advanced monitoring capabilities for decision support.

Unlike competitors that offer integrated systems with conventional technology and dated versions of components, Eurosets designed the ECMOLife with the best contemporary technology in the market regarding pumping, monitoring, and transporting, thereby improving the standard of care. The system includes the benefits from the advanced blood pump technology (magnetic levitating pump), which minimizes both hemolysis and friction to prevent coagulation. Further, ECMOLife is designed to ease operations in the ICU for professionals by offering a backup console integrated into the system, which automatically runs within 30 seconds during the primary device failure. This feature avoids pumping manually until the primary device is fixed and prevents the risk of complications.

The company was founded over two decades ago, in the heart of the Italian biomedical district Medolla (MO), and began manufacturing components and semi-finished products on behalf of third parties. Today, Eurosets Quality Assurance Department performs tests from the raw materials to the finished product, offers the customer post-marketing assistance and guarantees product quality following European and international regulatory requirements. It also implements the procedures required to maintain a certified Quality System per the medical device standards such as ISO13485 and MDSA for Canada, USA, Brazil, Australia and Japan.